Pfizer and BioNTech's Covid-19 vaccine candidate is among one of the most promising and awaited vaccines amid the pandemic. Finally, on Friday, they have submitted their vaccine shot for emergency administration in the US. In a joint statement, the firms mentioned they collected enough safety data to satisfy the regulators.
These become the first pharma companies to apply for a coronavirus vaccine's regulatory approval and once the shot is authorised which is expected by the middle of December, the company stated that they would ship the doses of the vaccine within the hours of authorisation.
